Retrieve available abstracts of 13 articles: HTML format
Single Articles
September 2025
SIMPKINS C, Toska E Sparking malignancy: nicotine as a driver of stemness and metastasis in
triple-negative breast cancer(dagger).
J Pathol. 2025 Sep 9. doi: 10.1002/path.6475. PubMedAbstract available
LI W, He J, Li J, Xie X, et al High-fat diets influence breast cancer progression by modulating CAF-immune cell
interactions through PLAT signaling.
J Pathol. 2025 Sep 3. doi: 10.1002/path.6452. PubMedAbstract available
August 2025
NGUYEN KA, McLemore LE, Ke Y, DePledge LN, et al Activation of PI3K and deletion of p53 in keratin 15-expressing mouse mammary
cells induces tumor heterogeneity and plasticity modeling metaplastic breast
cancer.
J Pathol. 2025 Aug 13. doi: 10.1002/path.6463. PubMedAbstract available
April 2025
KUO YC, Chen CL, Lee KL, Wang HF, et al Nicotine-driven enhancement of tumor malignancy in triple-negative breast cancer
via additive regulation of CHRNA9 and IGF1R.
J Pathol. 2025 Apr 17. doi: 10.1002/path.6423. PubMedAbstract available
March 2025
DEFILIPPI P, Nigrelli F, Arina P, Taverna D, et al A breast cancer PDX collection enriched in luminal (ER(+)) tumors and young
premenopausal patients to identify new therapeutic strategies for high-risk
patients(dagger).
J Pathol. 2025 Mar 27. doi: 10.1002/path.6418. PubMedAbstract available
RATZE MA, Enserink LN, Ishiyama N, van Kempen S, et al Afadin loss induces breast cancer metastasis through destabilisation of
E-cadherin to F-actin linkage.
J Pathol. 2025 Mar 3. doi: 10.1002/path.6394. PubMedAbstract available
January 2025
LU X, Gou Z, Chen H, Li L, et al Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and
immune exclusion in triple-negative breast cancer.
J Pathol. 2025 Jan 23. doi: 10.1002/path.6395. PubMedAbstract available
November 2024
HATSE S, Lambrechts Y, Antoranz Martinez A, De Schepper M, et al Dissecting the immune infiltrate of primary luminal B-like breast carcinomas in
relation to age.
J Pathol. 2024;264:344-356. PubMedAbstract available
October 2024
SEGATTO I, Mattevi MC, Rampioni Vinciguerra GL, Crestan N, et al A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to
capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6
inhibitors.
J Pathol. 2024 Oct 25. doi: 10.1002/path.6358. PubMedAbstract available
July 2024
CARVALHO R, Santos L, Conde I, Leitao R, et al Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast
cancer tropism to the brain.
J Pathol. 2024 Jul 29. doi: 10.1002/path.6319. PubMedAbstract available
CHEN M, van den Tempel N, Bhattacharya A, Yu S, et al Functional ex vivo DNA fibre assay to measure replication dynamics in breast
cancer tissue.
J Pathol. 2024 Jul 18. doi: 10.1002/path.6328. PubMedAbstract available
HUTTEN SJ, Messal HA, Lips EH, Sheinman M, et al Ductal carcinoma in situ develops within clonal fields of mutant cells in
morphologically normal ducts.
J Pathol. 2024;263:360-371. PubMedAbstract available
April 2024
MEYER B, Stirzaker C, Ramkomuth S, Harvey K, et al Detailed DNA methylation characterisation of phyllodes tumours identifies a
signature of malignancy and distinguishes phyllodes from metaplastic breast
carcinoma.
J Pathol. 2024;262:480-494. PubMedAbstract available